There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
These tactics included offering a low-cost, co-pay card to consumers and providing discounts to health plans and pharmacy benefit managers (read here). Have these approaches worked? Well, the answer depends on what those closely held Pfizer forecasts...
Packaging and samples of Norgestrel and Ethinyl Estradiol birth control tablets are seen in this handout photo released by the U.S. Food and Drug Administration (FDA) January 31, 2012. Pfizer Inc said on Tuesday it was recalling about 1 million packets... View Photo »
The science behind Excaliard’s lead compound aligns well with our R&D focus on new treatments for fibrosis and tissue remodeling. We view EXC 001 as being well positioned to potentially become a novel, transformative therapy in a space with limited available treatment options.
There is remarkably little high-quality research on the blood-brain barrier. If I were a young scientist looking for something important to do, I would consider discovering peripheral targets or else figuring out how to get various kinds of molecules...
Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. ...
Inc. said today that the U.S. Food and Drug Administration has agreed to a priority review of the company’s new drug application for an experimental pill to treat Transthyretin Familial Amyloid Polyneuropathy, a rare neurodegenerative disease also...
People walk past the Pfizer World headquarters in New York in this February 3, 2010 file photo. Pfizer Inc reported sharply lower quarterly earnings, hurt by generic forms of its Lipitor cholesterol drug, and the company trimmed its 2012 forecasts... View Photo »
Pfizer categorically denies the claims asserted in the plaintiffs' complaints ... Wyeth obtained its patents protecting Effexor XR lawfully, and the company intends to defend itself vigorously against these claims.
Inc research chief Mikael Dolsten said the company's experimental treatment for Alzheimer's disease is the drug industry's "best chance" to delay progression of the memory-robbing illness. Dolsten, speaking at the BIO CEO and investor conference in New...
Other co-hosts are not associated with the financial services industry, such as Tom Bernstein, president of Chelsea Piers LP; and Kevin Ryan; the chief executive officer of Gilt Groupe Inc. ; and Sally Susman, an executive vice president of Pfizer Inc.
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces the Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral... Full Article
This Jan. 30, 2012 photo, shows boxes of the drug Relpax made by Pfizer, in Surfside, Fla. Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection. It still beat...
View Photo »Packaging and samples of Norgestrel and Ethinyl Estradiol birth control tablets are seen in this handout photo released by the U.S. Food and Drug Administration (FDA) January 31, 2012. Pfizer Inc said on Tuesday it was recalling about 1 million packets of birth control pills in the...
View Photo »In this Jan. 30, 2012 photo, a row of ChapStick containers is on display at a Mirmarar, Fla. drug store. Pfizer Inc. said Tuesday, Jan. 31, 2012, that its fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol...
View Photo »SANDWICH, ENGLAND - AUGUST 17: Chancellor George Osborne visits Pfizer's pharmaceutical science lab which is situated at Discovery Park, on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including...
View Photo »Graphic shows annual sales of Pfizer's Lipitor and other cholesterol-fighting drugs.
View Photo »A prescription bottle of Lipitor(atorvastain calcium) tablets made by Pfizer and distributed by Parke-Davis is seen November 30, 2011 in Washington, DC. Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on November 30, 2011,...
View Photo »This undated photo provided by by Watson Pharmaceuticals Inc. , shows Atorvastatin Calcium tablets, or generic Lipitor, which is being sold under a deal with Pfizer. Cholesterol blockbuster Lipitor is so valuable to its maker that Pfizer Inc. is practically paying people to keep taking...
View Photo »In this product image provided by Pfizer Inc. , the drug Xalkori is displayed. Pfizer Inc.'s just-approved Xalkori, the first new medicine in several years for deadly lung cancer, shows the value of a new research standard: precisely targeting rare diseases linked to gene variants.
View Photo »SANDWICH, ENGLAND - AUGUST 17: A general view of part of the Pfizer Pharmaceutical company at Discovery Park on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including the park at Sandwhich, Kent.
View Photo »SANDWICH, ENGLAND - AUGUST 17: A man walks out of Discovery Park, home of the Pfizer Pharmaceutical company on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including the park at Sandwhich, Kent.
View Photo »SANDWICH, ENGLAND - AUGUST 17: Trees surround the grounds of Discovery Park, home of the Pfizer Pharmaceutical company on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including the park at...
View Photo »SANDWICH, ENGLAND - AUGUST 17: Chancellor George Osborne (C) and science minister David Willetts (L) visit Pfizer's pharmaceutical company which is situated at Discovery Park, on August 17, 2011 in Sandwich, England. The government has announced today locations for several new...
View Photo »SANDWICH, ENGLAND - AUGUST 17: Chancellor George Osborne looks through a microscope at Pfizer's pharmaceutical science lab on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including the park at...
View Photo »SANDWICH, ENGLAND - AUGUST 17: Chancellor George Osborne poses for a portrait at Discovery Park, home of pharmaceutical Company Pfizer, on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including...
View Photo »NEW YORK, NY - JANUARY 12: Former TODAY' Show producer Beryl Pfizer attends the 'TODAY' Show 60th anniversary celebration at The Edison Ballroom on January 12, 2012 in New York City.
View Photo »FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc. , in Willingboro, N.J. Cholesterol blockbuster Lipitor is so valuable to Pfizer Inc. that the drug giant is practically paying people to keep taking it after generic rivals hit the...
View Photo »FILE - In this file photo Jan. 31, 2011, the Pfizer logo is displayed at the drug company's world headquarters in New York. Pfizer Inc. , the world's largest maker of prescription drugs, is lowering its prices in Europe 4 to 6 percent, double the usual rate. The company doesn't expect...
View Photo »This undated product image provided by AstraZeneca shows the pharmaceutical company's cholesterol drug Crestor. AstraZeneca PLC's big gamble, an attempt to prove its top-selling drug works better than rival cholesterol blockbuster Lipitor, appears to have backfired. A study meant to...
View Photo »SANDWICH, ENGLAND - AUGUST 17: The Pfizer Pharmaceutical company logo is displayed at Discovery Park, on August 17, 2011 in Sandwich, England. The government has announced today locations for several new 'enterprise zones' across the England including the park at Sandwhich, Kent. The...
View Photo »A victim is carried by her father during the presentation of cheques by the Healthcare/Meningitis Trust Fund in Nigeria's northern city of Kano August 11, 2011. The parents of four Nigerian children who died during a 1996 meningitis outbreak in a case involving accusations of wrongful...
View Photo »Claimants receive a dummy cheque from the Healthcare/Meningitis Trust Fund during a presentation in Nigeria's northern city of Kano August 11, 2011. The parents of four Nigerian children who died during a 1996 meningitis outbreak in a case involving accusations of wrongful testing...
View Photo »This Jan. 30, 2012 photo, shows boxes of the drug Relpax made by Pfizer, in Surfside, Fla. Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection. It still beat...
View Photo »The science behind Excaliard’s lead compound aligns well with our R&D focus on new treatments for fibrosis and tissue remodeling. We view EXC 001 as being well positioned to potentially become a novel, transformative therapy in a space with limited available treatment options.
Pfizer categorically denies the claims asserted in the plaintiffs' complaints ... Wyeth obtained its patents protecting Effexor XR lawfully, and the company intends to defend itself vigorously against these claims.
Pfizer is the best marketing pharmaceutical company in the world ... It’s a master at marketing drugs. It should not be surprising that they’re going to try some interesting things to squeeze out all the value from that brand.
As a result, patients receive Lipitor at co-pays comparable to generics. Participation in Pfizer's programs by a health plan is entirely voluntary.
We are concerned that the (benefits management companies) may charge health plan sponsors, including employers and Medicare Part D, full price for brand name Lipitor from Dec. 1, 2011 through May 31, 2012, while pocketing the discount from Pfizer
Pfizer has made $100 billion on Lipitor. It has received a very great reward for its work developing and marketing the drug ... Now the consumers are supposed to get the benefit. Let us all hope this happens. If it does not, it says something about our system.
According to Marketplace, on Friday Lipitor will go off patent. On Thursday, the Indian drug company Ranbaxy will launch its generic at a low price. Pfizer will also lower the price of Lipitor to the generic levels.
While we expect Ranbaxy to launch on time, the potential upside from Lipitor could be impacted by Pfizer’s aggressive strategy, possible FDA penalty, delay in launch or its launch with a partner.
Pfizer is certainly in trouble with the Lipitor expiration but has a host of drugs that could make up for the lost revenue
I know if I get Lipitor, I know it's coming from Pfizer.
Pfizer won't give up Lipitor easily
For Pfizer, pharmaceutical counterfeiting is first and foremost an issue of patient health and safety
CPI reports that the measure was promoted by a medical group with a history of ties to Pfizer Inc., which makes the cholesterol-lowering drug Lipitor. Campaign finance reports show that Perry received more money from Pfizer than any other political candidate nationwide over the last six years
CPI reports that the measure was promoted by a medical group with a history of ties to Pfizer Inc., which makes the cholesterol-lowering drug Lipitor. Campaign finance reports show that Perry received more money from Pfizer than any other political candidate nationwide over the last six years
